QUESTCOR PHARMACEUTICALS INC 4
4 · QUESTCOR PHARMACEUTICALS INC · Filed Oct 16, 2013
Insider Transaction Report
Form 4
THOMPSON VIRGIL D
Director
Transactions
- Sale
Common Stock
2013-10-14$60.86/sh−900$54,770→ 29,867 total - Exercise/Conversion
Common Stock
2013-10-14$4.50/sh+2,500$11,250→ 32,367 total - Exercise/Conversion
Stock Option (right to buy)
2013-10-14−2,500→ 0 totalExercise: $4.50Exp: 2018-02-27→ Common Stock (2,500 underlying) - Sale
Common Stock
2013-10-14$60.30/sh−1,600$96,484→ 30,767 total
Footnotes (3)
- [F1]Non-qualified stock options were granted under the Company's 2006 Equity Incentive Award Plan.
- [F2]The option was granted on 02/29/2008 for the right to buy 7,500 shares of common stock of the Issuer. The options vested 100% on the date of grant.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.71-$60.71 and $60.72-$60.99, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.